You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
南京醫藥(600713.SH)子公司擬共同設立南京新醫匯 打造現代醫藥產業創新科技平台
格隆匯 07-15 16:38

格隆匯7月15日丨南京醫藥(600713.SH)公佈,公司全資子公司南京華東醫藥有限責任公司(以下簡稱:“南京華東醫藥”)擬與萬谷企業管理集團有限公司(以下簡稱:“萬谷公司”)共同以現金方式出資1000萬元(人民幣,下同)設立南京新醫匯運營管理有限公司(暫定名,以工商登記核准為準,以下簡稱“南京新醫匯”、“合資公司”)。

南京新醫匯以協議方式承租南京華東醫藥所屬位於南京市玄武區太平門街55號辦公場所的房屋及相應土地,租賃期限為12年,租金總額為8037.63萬元。

本次投資按照城市“硅巷”經濟發展方向,將位於南京太平門街55號的房屋,打造為以大健康為主導的現代醫藥產業創新科技平台,使之成為南京市玄武區“硅巷”經濟的“名片”,實現資產的保值與增值,最終達到雙方以及社會效益共贏的成效。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account